Eric Grannon is based in the Washington, DC office of White & Case LLP, where he helps clients with antitrust matters including civil and criminal defence as well as counselling for mergers and acquisitions and settlements of pharmaceutical patent litigation. He returned to White & Case after serving as counsel to the assistant attorney general in charge of the Antitrust Division of the Department of Justice in 2003–2004, where he helped formulate US antitrust enforcement policy and manage the civil and criminal investigations and court cases brought by the Antitrust Division.
In private practice, Mr Grannon has argued in district courts across the country, including an antitrust jury trial, argued appeals in the Eleventh and DC Circuits, and worked on 10 matters before the US Supreme Court, nine of which were antitrust cases.
Mr Grannon currently serves as lead trial counsel for two pharmaceutical companies defending against both government and private antitrust claims in FTC v Actavis, and he previously served as counsel of record for those companies before the US Supreme Court. He has counselled more than 30 pharmaceutical patent settlements that have avoided challenge by the FTC and private plaintiffs. He also has helped pharmaceutical clients obtain merger clearance in the US.
In 2015, Chambers USA said: ‘Eric Grannon has a strong reputation in the market for expertise in antitrust litigation. He has been particularly active of late in the pharmaceutical industry in connection with “reverse payment” cases.’